Has Jahangir Cyrus, MD received payments from drug or device companies?

Yes. Drug and device makers reported $155,418 in general payments to Jahangir Cyrus, MD across 621 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Jahangir Cyrus, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Jahangir Cyrus, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Jahangir Cyrus, MD

Endocrinology, Diabetes & Metabolism · Louisville, KYNPI 1558306092

Payments from drug & device makers

$155,418in general payments, 2019–2025

Across 621 payments — averaging $250.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Boehringer Ingelheim$43K
Lilly USA, LLC$27K
Sanofi-aventis U.S. LLC$24K
Bayer$23K
AstraZeneca$15K
Mannkind Corporation$6K
plus $18K from 34 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Boehringer Ingelheim	105	$42,600
Lilly USA, LLC	52	$27,350
Sanofi-aventis U.S. LLC	51	$23,612
Bayer	31	$22,900
AstraZeneca(2 entities)	38	$14,699
Mannkind Corporation	25	$5,866
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	22	$5,378
Merck	22	$3,846
Clarus Therapeutics Inc.	5	$2,511
AbbVie	14	$1,772
Corcept Therapeutics	1	$1,400
Novo Nordisk	87	$874
Amgen	34	$415
Amarin Pharma, Inc.	30	$408
Medtronic(2 entities)	10	$392
Abbott	16	$318
Johnson & Johnson	28	$233
Xeris Pharmaceuticals, Inc.	9	$177
Amneal Pharmaceuticals LLC	6	$126
Regeneron Healthcare Solutions, Inc.	4	$77
IBSA Pharma Inc.	3	$42
Tandem Diabetes Care, Inc.	3	$38
Valeritas, Inc.	3	$35
Vivus LLC	2	$32
Shire North American Group Inc	2	$31
GSK	2	$31
Axsome Therapeutics, Inc.	2	$30
Radius Health, Inc.	2	$27
Averitas Pharma Inc.	1	$27
BD	1	$27
Nevro Corp.	1	$20
Ipsen Biopharmaceuticals, Inc	1	$19
Therapeuticsmd, Inc.	1	$16
Insulet Corporation	1	$16
Lifescan, Inc.	1	$15
Biohaven Pharmaceutical Holding Company Ltd.	1	$13
E.r. Squibb & Sons, L.L.C.	1	$12
Senseonics, Incorporated	1	$12
Currax Pharmaceuticals LLC	1	$12
Dexcom, Inc.	1	$11

How this compares

$155,418 in reported general payments places this provider in the 85th percentile of 90 endocrinology, diabetes & metabolism providers in Kentucky.

See all endocrinology, diabetes & metabolism providers in Kentucky →

Medicare billing

Part B allowed, 2024

$1,484

Medicare patients

Services billed

183

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other endocrinology, diabetes & metabolism in Louisville

Harold BaysLouisville$12.9M
Hisham AlrefaiLouisville$720K
Sathya KrishnasamyLouisville$263K
Mehdi PoorkayLouisville$81K
Sri Prakash MokshagundamLouisville$73K
Stephen WintersLouisville$21K
Angelino YsonLouisville$15K
Mary SelfLouisville$14K
Omolara FakunleLouisville$13K
Kaitlyn TuckerLouisville$9K

See the full list for Kentucky →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →